Demant AS ADR WILYY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $23.36
- Day Range
- $24.80–24.80
- 52-Week Range
- $13.45–24.80
- Bid/Ask
- $25.41 / $27.14
- Shares Outstanding
- 421.80M
- Market Cap
- $10.46B
- Volume/Avg
- 349 / 1,014
Key Statistics
- Price/Earnings (Normalized)
- 25.98
- Price/Sales
- 2.72
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Demant is a Denmark-based manufacturer and distributor of hearing solutions, such as hearing aid devices and diagnostic equipment. More than 80% of the company's sales come from North America and Europe.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 26,616
- Website
- https://www.demant.com
Competitors
Valuation
|
Metric
|
WILYY
|
SOON
|
|---|---|---|
Price/Earnings (Normalized) | 25.98 | 26.64 |
Price/Book Value | 6.09 | 6.07 |
Price/Sales | 2.72 | 4.42 |
Price/Cash Flow | 15.68 | 20.62 |
Price/Earnings
WILYY
SOON
Financial Strength
|
Metric
|
WILYY
|
SOON
|
|---|---|---|
Quick Ratio | 0.54 | 1.17 |
Current Ratio | 0.82 | 1.75 |
Interest Coverage | 6.70 | 23.14 |
Quick Ratio
WILYY
SOON
Profitability
|
Metric
|
WILYY
|
SOON
|
|---|---|---|
Return on Assets (Normalized) | 6.76% | 11.07% |
Return on Equity (Normalized) | 24.80% | 24.50% |
Return on Invested Capital (Normalized) | 9.75% | 16.97% |
Return on Assets
WILYY
SOON
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|^hSm@x? | LOCK|?%%Wj | $178B | |||
| Medtronic PLC
MDT
| LOCK|!BZW&%F | LOCK|%PjM> | $119B | |||
| Stryker Corp
SYK
| LOCK|KJWP@^X | LOCK|M^ | $108B | |||
| Boston Scientific Corp
BSX
| LOCK|$TB!>N | LOCK|$V>$ | $63B | |||
| Edwards Lifesciences Corp
EW
| LOCK|GF<$^hJw | LOCK|rGwp^ | $49B | |||
| DexCom Inc
DXCM
| LOCK|RRn^!&! | LOCK|>n<h! | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|<<r>BS | LOCK|>v | $31B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|D@ | LOCK|l$& | $24B | |||
| Steris PLC
STE
| LOCK|%^tW@> | LOCK|%T%! | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|YqKF>xQ | LOCK|T<% | $18B |
United States